img

Global Long-acting and Short-acting Oral Contraceptives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Long-acting and Short-acting Oral Contraceptives Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.
Long-acting and Short-acting Oral Contraceptives report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Long-acting and Short-acting Oral Contraceptives market is projected to reach US$ 765.5 million in 2029, increasing from US$ 611 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Private Clinics are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Long-acting and Short-acting Oral Contraceptives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Paladin Labs
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Mankind
Piramal
Allergan
Segment by Type
Combined Contraceptive Pill
Low Dose Oral Contraceptive

Segment by Application


Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Long-acting and Short-acting Oral Contraceptives market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-acting and Short-acting Oral Contraceptives, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-acting and Short-acting Oral Contraceptives industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Long-acting and Short-acting Oral Contraceptives in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-acting and Short-acting Oral Contraceptives introduction, etc. Long-acting and Short-acting Oral Contraceptives Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Long-acting and Short-acting Oral Contraceptives market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Long-acting and Short-acting Oral Contraceptives Market Overview
1.1 Long-acting and Short-acting Oral Contraceptives Product Overview
1.2 Long-acting and Short-acting Oral Contraceptives Market Segment by Type
1.2.1 Combined Contraceptive Pill
1.2.2 Low Dose Oral Contraceptive
1.3 Global Long-acting and Short-acting Oral Contraceptives Market Size by Type
1.3.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Overview by Type (2018-2029)
1.3.2 Global Long-acting and Short-acting Oral Contraceptives Historic Market Size Review by Type (2018-2024)
1.3.3 Global Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Type (2018-2024)
1.4.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Type (2018-2024)
2 Global Long-acting and Short-acting Oral Contraceptives Market Competition by Company
2.1 Global Top Players by Long-acting and Short-acting Oral Contraceptives Sales (2018-2024)
2.2 Global Top Players by Long-acting and Short-acting Oral Contraceptives Revenue (2018-2024)
2.3 Global Top Players by Long-acting and Short-acting Oral Contraceptives Price (2018-2024)
2.4 Global Top Manufacturers Long-acting and Short-acting Oral Contraceptives Manufacturing Base Distribution, Sales Area, Product Type
2.5 Long-acting and Short-acting Oral Contraceptives Market Competitive Situation and Trends
2.5.1 Long-acting and Short-acting Oral Contraceptives Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Long-acting and Short-acting Oral Contraceptives Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2022)
2.7 Date of Key Manufacturers Enter into Long-acting and Short-acting Oral Contraceptives Market
2.8 Key Manufacturers Long-acting and Short-acting Oral Contraceptives Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Long-acting and Short-acting Oral Contraceptives Status and Outlook by Region
3.1 Global Long-acting and Short-acting Oral Contraceptives Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Long-acting and Short-acting Oral Contraceptives Historic Market Size by Region
3.2.1 Global Long-acting and Short-acting Oral Contraceptives Sales in Volume by Region (2018-2024)
3.2.2 Global Long-acting and Short-acting Oral Contraceptives Sales in Value by Region (2018-2024)
3.2.3 Global Long-acting and Short-acting Oral Contraceptives Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Region
3.3.1 Global Long-acting and Short-acting Oral Contraceptives Sales in Volume by Region (2024-2029)
3.3.2 Global Long-acting and Short-acting Oral Contraceptives Sales in Value by Region (2024-2029)
3.3.3 Global Long-acting and Short-acting Oral Contraceptives Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Long-acting and Short-acting Oral Contraceptives by Application
4.1 Long-acting and Short-acting Oral Contraceptives Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Private Clinics
4.1.3 Retail Pharmacies
4.1.4 E-Commerce
4.2 Global Long-acting and Short-acting Oral Contraceptives Market Size by Application
4.2.1 Global Long-acting and Short-acting Oral Contraceptives Market Size Overview by Application (2018-2029)
4.2.2 Global Long-acting and Short-acting Oral Contraceptives Historic Market Size Review by Application (2018-2024)
4.2.3 Global Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Application (2018-2024)
4.3.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Breakdown by Application (2018-2024)
5 North America Long-acting and Short-acting Oral Contraceptives by Country
5.1 North America Long-acting and Short-acting Oral Contraceptives Historic Market Size by Country
5.1.1 North America Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2018-2024)
5.1.3 North America Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2018-2024)
5.2 North America Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Country
5.2.1 North America Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2024-2029)
5.2.2 North America Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2024-2029)
6 Europe Long-acting and Short-acting Oral Contraceptives by Country
6.1 Europe Long-acting and Short-acting Oral Contraceptives Historic Market Size by Country
6.1.1 Europe Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2018-2024)
6.1.3 Europe Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2018-2024)
6.2 Europe Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Country
6.2.1 Europe Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2024-2029)
6.2.2 Europe Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2024-2029)
7 Asia-Pacific Long-acting and Short-acting Oral Contraceptives by Region
7.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Historic Market Size by Region
7.1.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Region
7.2.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales in Value by Region (2024-2029)
8 Latin America Long-acting and Short-acting Oral Contraceptives by Country
8.1 Latin America Long-acting and Short-acting Oral Contraceptives Historic Market Size by Country
8.1.1 Latin America Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2018-2024)
8.1.3 Latin America Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2018-2024)
8.2 Latin America Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Country
8.2.1 Latin America Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2024-2029)
8.2.2 Latin America Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2024-2029)
9 Middle East and Africa Long-acting and Short-acting Oral Contraceptives by Country
9.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Historic Market Size by Country
9.1.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Forecasted Market Size by Country
9.2.1 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Products Offered
10.1.5 Bayer Recent Development
10.2 Paladin Labs
10.2.1 Paladin Labs Company Information
10.2.2 Paladin Labs Introduction and Business Overview
10.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Products Offered
10.2.5 Paladin Labs Recent Development
10.3 Theramex (Teva)
10.3.1 Theramex (Teva) Company Information
10.3.2 Theramex (Teva) Introduction and Business Overview
10.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Products Offered
10.3.5 Theramex (Teva) Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Products Offered
10.4.5 Pfizer Recent Development
10.5 Apotex
10.5.1 Apotex Company Information
10.5.2 Apotex Introduction and Business Overview
10.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Products Offered
10.5.5 Apotex Recent Development
10.6 HRA Pharma
10.6.1 HRA Pharma Company Information
10.6.2 HRA Pharma Introduction and Business Overview
10.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Products Offered
10.6.5 HRA Pharma Recent Development
10.7 HLL Life Care
10.7.1 HLL Life Care Company Information
10.7.2 HLL Life Care Introduction and Business Overview
10.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Products Offered
10.7.5 HLL Life Care Recent Development
10.8 Mankind
10.8.1 Mankind Company Information
10.8.2 Mankind Introduction and Business Overview
10.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Products Offered
10.8.5 Mankind Recent Development
10.9 Piramal
10.9.1 Piramal Company Information
10.9.2 Piramal Introduction and Business Overview
10.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Products Offered
10.9.5 Piramal Recent Development
10.10 Allergan
10.10.1 Allergan Company Information
10.10.2 Allergan Introduction and Business Overview
10.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Products Offered
10.10.5 Allergan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Long-acting and Short-acting Oral Contraceptives Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Long-acting and Short-acting Oral Contraceptives Industrial Chain Analysis
11.4 Long-acting and Short-acting Oral Contraceptives Market Dynamics
11.4.1 Long-acting and Short-acting Oral Contraceptives Industry Trends
11.4.2 Long-acting and Short-acting Oral Contraceptives Market Drivers
11.4.3 Long-acting and Short-acting Oral Contraceptives Market Challenges
11.4.4 Long-acting and Short-acting Oral Contraceptives Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Long-acting and Short-acting Oral Contraceptives Distributors
12.3 Long-acting and Short-acting Oral Contraceptives Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Combined Contraceptive Pill
Table 2. Major Company of Low Dose Oral Contraceptive
Table 3. Global Long-acting and Short-acting Oral Contraceptives Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 5. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US& Million)
Table 7. Global Long-acting and Short-acting Oral Contraceptives Market Share in Value by Type (2018-2024)
Table 8. Global Long-acting and Short-acting Oral Contraceptives Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (K Units)
Table 10. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type (2024-2029)
Table 13. Global Long-acting and Short-acting Oral Contraceptives Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (K Units)
Table 15. North America Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2018-2024)
Table 17. Europe Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2018-2024)
Table 21. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Long-acting and Short-acting Oral Contraceptives Sales by Company (2018-2024) & (K Units)
Table 25. Global Long-acting and Short-acting Oral Contraceptives Sales Share by Company (2018-2024)
Table 26. Global Long-acting and Short-acting Oral Contraceptives Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Long-acting and Short-acting Oral Contraceptives Revenue Share by Company (2018-2024)
Table 28. Global Market Long-acting and Short-acting Oral Contraceptives Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Long-acting and Short-acting Oral Contraceptives Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Long-acting and Short-acting Oral Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting and Short-acting Oral Contraceptives as of 2022)
Table 32. Date of Key Manufacturers Enter into Long-acting and Short-acting Oral Contraceptives Market
Table 33. Key Manufacturers Long-acting and Short-acting Oral Contraceptives Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Long-acting and Short-acting Oral Contraceptives Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 37. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Region (2018-2024)
Table 40. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 42. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Region (2024-2029)
Table 45. Global Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Long-acting and Short-acting Oral Contraceptives Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (K Units)
Table 48. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application (2018-2024)
Table 51. Global Long-acting and Short-acting Oral Contraceptives Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (K Units)
Table 53. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application (2024-2029)
Table 56. Global Long-acting and Short-acting Oral Contraceptives Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) (K Units)
Table 58. North America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) (K Units)
Table 60. Europe Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) (K Units)
Table 64. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 68. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2018-2024)
Table 71. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 72. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 76. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 80. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Country (2024-2029)
Table 107. Bayer Company Information
Table 108. Bayer Introduction and Business Overview
Table 109. Bayer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Bayer Long-acting and Short-acting Oral Contraceptives Product
Table 111. Bayer Recent Development
Table 112. Paladin Labs Company Information
Table 113. Paladin Labs Introduction and Business Overview
Table 114. Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product
Table 116. Paladin Labs Recent Development
Table 117. Theramex (Teva) Company Information
Table 118. Theramex (Teva) Introduction and Business Overview
Table 119. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product
Table 121. Theramex (Teva) Recent Development
Table 122. Pfizer Company Information
Table 123. Pfizer Introduction and Business Overview
Table 124. Pfizer Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Long-acting and Short-acting Oral Contraceptives Product
Table 126. Pfizer Recent Development
Table 127. Apotex Company Information
Table 128. Apotex Introduction and Business Overview
Table 129. Apotex Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Apotex Long-acting and Short-acting Oral Contraceptives Product
Table 131. Apotex Recent Development
Table 132. HRA Pharma Company Information
Table 133. HRA Pharma Introduction and Business Overview
Table 134. HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product
Table 136. HRA Pharma Recent Development
Table 137. HLL Life Care Company Information
Table 138. HLL Life Care Introduction and Business Overview
Table 139. HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product
Table 141. HLL Life Care Recent Development
Table 142. Mankind Company Information
Table 143. Mankind Introduction and Business Overview
Table 144. Mankind Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Mankind Long-acting and Short-acting Oral Contraceptives Product
Table 146. Mankind Recent Development
Table 147. Piramal Company Information
Table 148. Piramal Introduction and Business Overview
Table 149. Piramal Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Piramal Long-acting and Short-acting Oral Contraceptives Product
Table 151. Piramal Recent Development
Table 152. Allergan Company Information
Table 153. Allergan Introduction and Business Overview
Table 154. Allergan Long-acting and Short-acting Oral Contraceptives Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Allergan Long-acting and Short-acting Oral Contraceptives Product
Table 156. Allergan Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Long-acting and Short-acting Oral Contraceptives Market Trends
Table 160. Long-acting and Short-acting Oral Contraceptives Market Drivers
Table 161. Long-acting and Short-acting Oral Contraceptives Market Challenges
Table 162. Long-acting and Short-acting Oral Contraceptives Market Restraints
Table 163. Long-acting and Short-acting Oral Contraceptives Distributors List
Table 164. Long-acting and Short-acting Oral Contraceptives Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting and Short-acting Oral Contraceptives Product Picture
Figure 2. Global Long-acting and Short-acting Oral Contraceptives Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Long-acting and Short-acting Oral Contraceptives Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Long-acting and Short-acting Oral Contraceptives Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Combined Contraceptive Pill
Figure 6. Global Combined Contraceptive Pill Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Low Dose Oral Contraceptive
Figure 8. Global Low Dose Oral Contraceptive Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Long-acting and Short-acting Oral Contraceptives Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Type in 2022 & 2029
Figure 11. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type in 2022
Figure 12. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type in 2022
Figure 13. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type in 2022
Figure 14. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type in 2022
Figure 17. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting and Short-acting Oral Contraceptives Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting and Short-acting Oral Contraceptives Revenue in 2022
Figure 23. Long-acting and Short-acting Oral Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital Pharmacies
Figure 25. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Private Clinics
Figure 27. Global Private Clinics Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Retail Pharmacies
Figure 29. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of E-Commerce
Figure 31. Global E-Commerce Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Long-acting and Short-acting Oral Contraceptives Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Long-acting and Short-acting Oral Contraceptives Sales Market Share by Application in 2022 & 2029
Figure 34. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application in 2022
Figure 35. North America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application in 2022
Figure 36. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application in 2022
Figure 37. Europe Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application in 2022
Figure 40. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Long-acting and Short-acting Oral Contraceptives Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Long-acting and Short-acting Oral Contraceptives Manufacturing Cost Structure
Figure 45. Long-acting and Short-acting Oral Contraceptives Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries